Treatment duration-dependent efficacy of Japanese cedar pollen sublingual immunotherapy: Evaluation of a phase II/III trial over three pollen dispersal seasons
Background: We conducted a randomized, placebo-controlled, double-blind clinical trial to investigate the optimal dose and long-term efficacy and safety of Japanese cedar (JC) pollen tablets for SLIT (JapicCTI-142579). Here, we report details of the effects of the JC pollen SLIT tablet on rhinitis a...
Main Authors: | Syuji Yonekura, Minoru Gotoh, Shinya Kaneko, Keishi Kanazawa, Yoshie Takeuji, Kimihiro Okubo, Yoshitaka Okamoto |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-10-01
|
Series: | Allergology International |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1323893019300620 |
Similar Items
-
An analysis of factors related to the effect of sublingual immunotherapy on Japanese cedar pollen induced allergic rhinitis
by: Syuji Yonekura, et al.
Published: (2018-04-01) -
Sublingual Immunotherapy for Japanese Cedar Pollinosis
by: Kimihiro Okubo, et al.
Published: (2009-01-01) -
Sublingual Immunotherapy for Japanese Cedar Pollinosis
by: Minoru Gotoh, et al.
Published: (2005-01-01) -
Safety profile and immunological response of dual sublingual immunotherapy with house dust mite tablet and Japanese cedar pollen tablet
by: Minoru Gotoh, et al.
Published: (2020-01-01) -
A Randomized Double-Blind Comparative Study of Sublingual Immunotherapy for Cedar Pollinosis
by: Kimihiro Okubo, et al.
Published: (2008-01-01)